Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and feasibility of S-Caine patch use in children under 3 years
2019-002094-55Phase 4Completed
- Sponsor
- UZ Brussel
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of S-Caine, sponsored by UZ Brussel. Primary endpoints: Plasma lidocaine levels and Adverse events. Started Aug 2019; status: completed.
02
Drugs
S-Caine
Beyond the preview
Go deeper on 2019-002094-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002094-55.